Glooko mHealth Advantage Study

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 197 participants.

Also called NCT02974816

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 197 participants (enrolled count) (from the registry)
Sponsor
Glooko (from the registry)
Registry
  • NCT NCT02974816
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
United States (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02974816. Randomized; no masking; primary purpose treatment. Start 2017-05-15 (actual); primary completion 2020-04-17 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Glooko mHealth Advantage Study
Condition
Diabetes Mellitus, Type 2
Intervention (Device)
Glooko's mobile application
Lead sponsor
Glooko (class: industry)

Record details

Record id
cardio:ct-nct02974816
Content hash
cc22c9675e6a73c260ebcb24632bce841019d9c1034b06924622d5e5a32e337e